Vanguard Small-Cap ETF (VB) is a passively managed exchange-traded fund that seeks to track the CRSP US Small Cap Index before fees and expenses. The index represents U.S. companies falling roughly between the bottom 2% and 15% of the investable equity market by capitalization, creating a small-cap blend that spans both growth and value profiles. VB uses a full-replication approach, holding stocks in approximately the same proportions as the index.
The portfolio contains more than 1,300 holdings, which limits single-stock risk. Top positions include Credo Technology Group (CRDO), Jabil (JBL), Astera Labs (ALAB), Natera (NTRA), Revolution Medicines (RVMD), and EMCOR Group (EME), each representing well under 1% of assets. Sector exposure is led by industrials (about 20%) and technology (about 18%), with financial services and healthcare each near 12%–13%, followed by consumer cyclical and real estate. The fund carries a net expense ratio of 0.03%. I also checked the latest holdings breakdown using Tickeron’s AI tools to confirm the sector allocations.
Small-cap equities entered a more challenging phase during the latter part of 2026 after outperforming large caps through the first half of the year. The primary headwind has been interest rates: the 10-year U.S. Treasury yield moved above 5%, raising financing costs for smaller companies that rely more heavily on floating-rate debt and external capital. This asymmetry has disproportionately pressured longer-duration and less-profitable small caps even as large-cap leaders remained resilient.
At the same time, the domestic economy has stayed relatively firm. The S&P Global Manufacturing Purchasing Managers' Index reached its strongest reading in more than four years, and labor-market conditions remained broadly stable. Inflation, however, has lingered above target, with the Consumer Price Index (CPI) and core inflation measures keeping policymakers cautious. This combination of resilient activity and sticky inflation has supported cyclical industrial and financial names while restraining rate-sensitive growth segments, shaping a market environment that favors diversified, multi-sector exposure over concentrated bets.
VB has been essentially range-bound in recent weeks. Over the trailing 30 days, the fund advanced roughly 2%, while over the trailing quarter it was slightly lower, reflecting the flat performance of the small-cap complex as a whole. This is consistent with broader small-cap benchmarks, which gave back first-half leadership gains as longer-dated yields climbed.
The fund's sector mix helps explain this behavior. Its substantial industrials and technology exposure ties it to domestic manufacturing and the artificial-intelligence build-out, areas where many smaller suppliers of specialized equipment and components have continued to grow. Meanwhile, its healthcare weight includes biotechnology names that are more sensitive to financing conditions, and its financial services exposure remains linked to the path of interest rates. With earnings revisions mixed across the small-cap universe, VB's broad diversification has muted single-stock volatility, leaving macro factors such as Treasury yields and inflation expectations as the dominant drivers of recent performance.
Several structural factors are likely to shape VB's trajectory over the remainder of 2026 and beyond. Interest-rate policy remains central: additional Federal Reserve tightening would raise financing costs for smaller, more leveraged companies, while a pause or shift toward easing could relieve a key constraint on small-cap valuations. Inflation trends, particularly in energy and services, will influence that path.
Domestic economic growth is another important variable. Because small-cap revenue is heavily concentrated in the United States, VB is closely tied to manufacturing activity, consumer spending, and credit conditions. The artificial-intelligence build-out may continue to benefit specialized industrial and technology suppliers within the fund, though any slowdown in that capital-expenditure cycle would ripple across holdings. Healthcare innovation and biotechnology financing conditions, along with merger and acquisition activity, also represent potential catalysts. Investors should monitor sector rotation, earnings revisions among small-cap constituents, and capital flows into small-cap ETFs as signals of whether the current consolidation gives way to renewed leadership or further range-bound trading. One thing that stands out is how these macro variables could shift the relative performance of small caps versus large caps going forward.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery platform designed to help investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool enables users to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For those researching diversified small-cap strategies or identifying momentum and value setups across sectors, the screener provides a structured way to narrow the universe. I find it useful when comparing VB to similar funds in the space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for VB turned positive on October 20, 2026. Looking at past instances where VB's MACD turned positive, the stock continued to rise in 48 of 53 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VB's RSI Oscillator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on VB as a result. In 84 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
Following a +1.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where VB advanced for three days, in 270 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
VB moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
VB broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for VB entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallBlend